December 2021 EIPM Director’s Memo Dear Members of the Englander Institute, It’s always a pleasure to share the important work and contributions of our colleagues, especially those who are just beginning their careers. Over the next...
Read more
New Treatment Option for Advanced Urothelial Cancer Patients Shows Promise in a Phase 2 Clinical Trial A new treatment for advanced urothelial cancer was effective with tolerable side effects in an international, multi-center phase 2...
Read more July 2021 EIPM Director’s Memo Dear Members of the Englander Institute, June was a very busy and successful month for all of us at the Englander Institute. Our work was a major focus within the launch of WCM’s “We’re...
Read more